Abstract: A dose display mechanism for a drug delivery device is disclosed. The display mechanism has an elongated dose setting dial with both an external helical thread and external linear grooves extending from one end to the other end. A counter ring is mounted surrounding the setting dial. The counter ring has ribs on its inner surface which engage the grooves and permit the counter ring to move axially along the setting dial but prevent it from rotating relative to the setting dial. Indicia, in the form of digits, are arranged helically on the outer surface of the dose setting dial. The digits are spaced at a pitch which corresponds to the pitch of the external helical threads.
Type:
Grant
Filed:
March 26, 2007
Date of Patent:
June 19, 2012
Assignees:
Terumo Corp., sanofi-aventis Deutschland GmbH
Abstract: A counter mechanism useable with a dry powder inhaler is disclosed. The mechanism features first and second indicator members rotatable about a central axis. The indicator members have counting indicia visible to indicate inhaler doses remaining or dispensed. A coupling transmits rotary motion from the inhaler to the second indicator member when the inhaler is charged with a dose. A slave wheel, rotatable about an axis offset from the central axis, has a drive transfer wheel on one face and a gear on an opposite face. The gear engages the second indicator member, the drive transfer wheel intermittently engages and rotates the first indicator member in response to rotary motion of the second indicator member.
Type:
Grant
Filed:
May 28, 2010
Date of Patent:
December 27, 2011
Assignee:
Aventis Pharma Limited
Inventors:
Stephen J. Minshull, Duncan G. Young, Andrew J. Ledgeway, Simon P. Wells, Graham K. Lacy, Julian F. R. Swan
Abstract: An aqueous pharmaceutical composition which is capable of being sprayed into the nasal cavity of an individual and which comprises: (A) a pharmaceutically effective amount of solid particles of medicament which is effective in treating a bodily condition by virtue of its being present on the mucosal surfaces of the nasal cavity; and (B) a suspending agent in an amount effective to maintain said particles dispersed uniformly in the composition and to impart to the composition the following thixotropic properties: (i) the viscosity of the position in unsheared form is relatively high, with the composition being in gel-like form; (ii) as the composition is subjected to shear (shaken) in preparation for spraying, the viscosity of the composition becomes relatively low and such that the composition in the form of a mist flows readily into the nasal passages for deposit on the mucosal surfaces of the nasal cavity; and (D) in deposited form on the mucosal surfaces, the viscosity of the composition is relatively high